T1	Treatment 11 25	pyridostigmine
T2	Treatment 30 38	naloxone
T3	Treatment 654 657	TRH
T4	Treatment 951 1093	TRH tests were performed after an overnight (8 hours) fast, placebo administrations (control test), and after prolonged (56 hours) starvation.
T5	Treatment 1094 1295	TRH tests after prolonged starvation were performed either after placebos (in all subjects) or the administration of pyridostigmine (180 mg orally) (in 7 subjects, group 1); naloxone (0.8 mg in an i.v.
T6	Treatment 1296 1414	bolus injection) (in 7 subjects, group 2); or the combination of pyridostigmine and naloxone (in 7 subjects, group 3).
T7	Treatment 1487 1590	TRH plus placebo, TRH plus naloxone, TRH plus pyridostigmine, and TRH plus naloxone plus pyridostigmine
T8	Treatment 1780 1794	pyridostigmine
T9	Treatment 1799 1807	naloxone
T10	Treatment 2252 2266	pyridostigmine
T11	Treatment 2271 2274	TRH
